Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular
Oct 15, 2018
32:58
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.
Medtech Talk